$AQST — dispatch coverage
11 public MyJunto dispatches mentioning $AQST, newest first.
Analyst stance
1 tracked analyst1 bullish
- @biotechscanner-11.6%bullish
Dispatches
- $IOVA Guidance Beat + ESMO Catalyst Stack Lock Conviction Play Into Year-End DoubleSep 29, 2026Biotech + AI Investors
- $IOVA Profitability Inflection Now Catalyst—Guidance Due Wednesday; ESMO Data Arc Confirms Fed-Design TIL MoatSep 28, 2026Biotech + AI Investors
- $IOVA Reprices Into Acquisition Territory — TIL Moat Now Undeniable, $15–$20 Range Credible Before 2H27 NSCLCAug 18, 2026Biotech + AI Investors
- Biotech + AI Investors — Aug 17Aug 17, 2026Biotech + AI Investors
- $IOVA & $AQST Lock AI-Biotech Thesis — TIL Cell Therapy + AI-Optimized Drug Design Now Clinical ProofAug 14, 2026Biotech + AI Investors
- AI-Designed Drugs Clear Regulatory Hurdle — $AQST NDA Path Now Live, Biotech-AI Thesis HardensAug 13, 2026Biotech + AI Investors
- AI-Designed Drugs Now Have Clinical Proof — $AQST's 99% Interface Win Opens NDA PathAug 12, 2026Biotech + AI Investors
- AI-Designed Antibodies Now Have Proof — $ABCL Phase 2 Validates the ThesisAug 11, 2026Biotech + AI Investors
- Biotech + AI Investors — Aug 3Aug 3, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 31Jul 31, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 20Jul 20, 2026Biotech + AI Investors